CCRN
$9.18-0.17 (-1.82%)
Cross Country Healthcare, Inc.
Recent News
How The Narrative Is Shifting For Cross Country Healthcare (CCRN) After Mixed Margin Expectations
The updated analyst fair value estimate for Cross Country Healthcare now sits at US$11.67, compared with the prior US$9.93. This keeps the current target in the low double digits. This shift lines up with research that highlights a mix of optimism and caution, including raised targets clustered between roughly US$10 and the low to mid teens, as analysts weigh execution in higher margin areas against lingering risks. As you read on, you will see how these moving targets shape the evolving...
Does Cross Country Healthcare (CCRN) Have Strong Fundamentals?
Long Cast Advisers, an investment management firm, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. In Q4 2025, the Portfolio’s cumulative net return increased by 1%, but the cumulative portfolio for the year remained flat. Since its inception in November 2015, the portfolio has delivered a cumulative return […]
Cross Country Healthcare, Inc. Q4 2025 Earnings Call Summary
Moby summary of Cross Country Healthcare, Inc.'s Q4 2025 earnings call
Cross Country Healthcare Inc (CCRN) Q4 2025 Earnings Call Highlights: Navigating Revenue ...
Despite a challenging quarter, Cross Country Healthcare Inc (CCRN) leverages a strong cash position and innovative technology to drive future growth.
Cross Country Healthcare (CCRN) Earnings Call Transcript
Please note that certain statements made on this call may constitute forward-looking statements. As noted in our press release, forward-looking statements can vary materially from actual results and are subject to known and unknown risks, uncertainties, and other factors, including those contained in the company's 2024 Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as well as in other filings with the SEC.